FDA Launches PreCheck Program to Strengthen U.S. Drug Manufacturing and Reduce Dependence on China

TL;DR
The FDA announced the new PreCheck program to enhance U.S. drug manufacturing by streamlining regulatory processes and encouraging domestic production, aiming to reduce reliance on overseas sources for pharmaceuticals and active ingredients, with a public meeting scheduled for September 30, 2025.
Topics:businesshealth#domestic-production#drug-manufacturing#fda#health#pharmaceutical-supply-chain#precheck
- FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing fda.gov
- US FDA moves to boost domestic drug manufacturing after Trump push Reuters
- US drug supply chain exposure to China Brookings
- Toomey: Federal Procurement Can Incentivize New U.S. Pharmaceutical Production Coalition For A Prosperous America
- Senator Marshall: America Must Stand Up to China’s Drug Trap Senator Roger Marshall (.gov)
Want the full story? Read the original reporting
Read on fda.gov